Business
Halozyme Appoints New Chief Financial Officer
SAN DIEGO, Feb. 2, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Nicole LaBrosse has been promoted to the position of
About this update from Halozyme Therapeutics, Inc.
[{"type":"text","content":"SAN DIEGO, Feb. 2, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Nicole LaBrosse has been promoted to the position of senior vice president, chief financial officer, effective immediately. Ms. LaBrosse will succeed Elaine Sun, who is stepping down to pursue another opportunity. \nMs. LaBrosse brings over 18 years of public accounting and corporate finance experience to Halozyme. Ms. LaBrosse joined Halozyme in 2015 and has since held roles of growing responsibility within the Company. Most recently, Ms. LaBrosse served as Halozyme's vice president, finance and accounting since 2020. Previously, Ms. LaBrosse held the role of executive director, controller since 2017. During her tenure with Halozyme, Ms. LaBrosse has demonstrated leadership with important corporate initiatives including capital return, accessing capital markets, corporate restructuring and transitioning to a growing, profitable company. Prior to joining Halozyme, Ms. LaBrosse was with PricewaterhouseCoopers, LLP for over 10 years supporting clients across a broad range of activities including initial public offerings, complex technical accounting and SEC reporting. Ms. LaBrosse received her M.S. in accounting from the McCallum Graduate School of Business, Bentley College. She also holds a B.S. in corporate finance and accounting from Bentley College. Ms. LaBrosse is licensed in California as a certified public accountant (CPA).\n\"I am pleased to welcome Nicole to the executive management team as our new chief financial officer and delighted to promote a strong internal candidate who already knows the depth and breadth of our business so well,\" said Dr. Helen Torley, president and chief executive officer. \"Nicole has broad experience within the company and working with external advisors. She possesses the right financial and business skill set to support Halozyme's future growth. On behalf of the Board of Directors, I want to thank Elaine for her contributions to Halozyme and wish her success in her future endeavors.\"\n\"I am honored to be appointed as chief financial officer of Halozyme at such an exciting time in the company's growth,\" said Ms. LaBrosse. \"I have enjoyed working closely with our management team over the last several years and look forward to playing a bigger role in driving Halozyme's growth and buildin...